Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine ...

Bloomberg journalists discuss today's biggest winners and losers in the stock market. Listen for analysis on the companies ...

The Trump administration shared the outlines of how it plans to push drug companies to lower their prices in the U.S.

Moderna, Inc. (Nasdaq:MRNA), today announced that in consultation with the U.S. Food and Drug Administration (FDA), the Company has voluntarily withdrawn the pending Biologics License Application (BLA ...

The FDA will make it more costly to seek approval of Covid-19 vaccines, but Moderna's shareholder reacted favorable to the ...

Moderna has withdrawn its pending application for a combination vaccine for both the flu and Covid-19, saying it will resubmit later this year once it has more data.

The FDA announced yesterday that it will limit access to Covid-19 vaccines to people 65 years of age and older and others who ...

The vaccine maker, which has partnered with OpenAI since 2023, is rethinking how it does workforce planning thanks to the ...

In terms of liquidity and interest, the mean open interest for Moderna options trades today is 1389.55 with a total volume of ...

The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.